U.S. Medical Equipment Stock News

Redwire (NYSE:RDW) is retiring the Edge Autonomy brand and bringing its uncrewed aerial systems and defense technologies fully under the Redwire name. The company is reorganizing into two operating segments that combine its space and defense capabilities under a single corporate structure. This shift follows contract wins with DARPA and The Exploration Company and comes as demand for space based defense solutions draws more attention. For you as an investor, this move is about Redwire...

With no single headline event driving LeMaitre Vascular (LMAT) today, the story for investors centers on how its recent share performance and underlying financial profile line up with expectations. See our latest analysis for LeMaitre Vascular. At a share price of $85.80, LeMaitre Vascular has paired a 7.02% year to date share price return with an 88.03% three year total shareholder return, while the 1 year total shareholder return of a 13.10% decline suggests some of that earlier momentum...

IREN (NasdaqGS:IREN) has moved into the spotlight after securing a US$9.7b, five year AI cloud contract with Microsoft, a material deal that investors view as reshaping the company’s role in AI infrastructure. See our latest analysis for IREN. That Microsoft deal has arrived after a sharp run, with IREN showing a 35.92% 1 month share price return and a very large 1 year total shareholder return. This suggests momentum has been building despite a recent 6.16% 1 day pullback. If you are looking...

Pinterest is rolling out new AI tools aimed at supporting user well-being and lowering operating costs. The company is using open source AI models. Its CEO is pushing for responsible AI, including fair pay for creators and supportive regulation. Pinterest is partnering with Roku on a shoppable TV series that links entertainment directly to Pinterest powered shopping experiences. New collaborations with major brands and retailers are expanding shoppable content across the platform. At a...

Tradeweb Markets (TW) has drawn fresh attention after reporting record trading volumes for December and the fourth quarter, with average daily volume up more than 20% year-over-year across its electronic marketplaces. See our latest analysis for Tradeweb Markets. Despite the record December and fourth quarter trading volumes, Tradeweb’s recent price action has been softer. The 90 day share price return has declined by 6%, and the 1 year total shareholder return is 18.63% in the red. This is...

If you are trying to figure out whether Synopsys at around US$510 a share looks expensive or interesting, starting with a clear view of its valuation can help you decide where it fits in your watchlist. The stock has seen mixed returns, with a 10.2% gain over the last 30 days and a 6.4% gain year to date, but a 3.5% decline over the past year against a backdrop of a 46.3% return over 3 years and 92.0% over 5 years. Recent attention on Synopsys has largely centered on its role in software and...

Axsome Therapeutics (AXSM) has drawn fresh attention after recent trading, with the stock last closing at $184.50. For context, Axsome reports revenue of $561.263 million and a net loss of $229.527 million. See our latest analysis for Axsome Therapeutics. That recent 4.1% 1 day share price return sits within a strong run, with a 30 day share price return of 20.9% and a 1 year total shareholder return of 91.8%, suggesting positive momentum has been building for some time. If Axsome’s move has...

In recent days, Hut 8 has attracted heightened attention as investors and analysts reacted to its expanding partnership with AI firm Anthropic and growing demand from large cloud and AI customers, alongside new capacity rollouts at its Corpus Christi and River Bend sites. An interesting angle is how Hut 8’s work with experienced engineering and infrastructure partners is being viewed as lowering execution risk, reinforcing confidence in its role as a large-scale digital infrastructure...

Kratos Defense & Security Solutions (KTOS) recently drew fresh attention after opening a 55,000-square-foot hypersonic and payload integration facility in Princess Anne, Maryland. The move is being closely watched by investors focused on advanced defense programs. See our latest analysis for Kratos Defense & Security Solutions. That new hypersonic facility comes on the back of several contract and footprint updates in recent weeks, and the share price has reacted, with a 30 day share price...

Pure Storage (PSTG) has regained attention following its presentation at the Needham Growth Conference, the disclosure of a relationship with Meta, and the announcement of a new share repurchase program, all accompanied by supportive commentary from JPMorgan. See our latest analysis for Pure Storage. Despite the recent swing in sentiment, the 1-day share price return of a 3.9% decline and the 7-day share price return of a 7.1% decline sit alongside a 1-year total shareholder return that is...

Why Digital Realty Trust is on investors’ radar today Digital Realty Trust (DLR) is back in focus after its recent trading performance, providing investors with fresh data points to reassess this data center REIT and how its current valuation compares with its fundamentals. The stock closed at $159.62, with a 1-day return of 2.43%, a 1-month return of 6.42%, a 3-month return showing a 7.42% decline, and a 1-year total return reflecting a 10.36% decline. See our latest analysis for Digital...

Astera Labs (ALAB) has been in focus after RBC Capital initiated coverage, citing retimer demand and upcoming Scorpio-P and Scorpio-X product ramps as key factors that investors are now weighing more closely. See our latest analysis for Astera Labs. The RBC initiation has come after a strong run, with the share price at US$183.75 and a 30 day share price return of 11.77% feeding into a 1 year total shareholder return of 47.70%. This suggests momentum has been building as investors reassess...

NANO Nuclear Energy Inc. announced that it had signed a Memorandum of Understanding with Ameresco to explore integrating advanced modular micro reactors, including the KRONOS MMR™ energy system, with Ameresco's engineering, procurement, and construction capabilities for potential deployment on federal and commercial sites. This collaboration framework positions Ameresco to apply its project delivery expertise to early-stage nuclear micro reactor concepts across siting, development,...

Halliburton (NYSE:HAL) has promoted Casey Maxwell to President, Western Hemisphere, effective February 1, 2026. The company is emphasizing capital discipline, with a focus on lower capital expenditure and prioritizing free cash flow. Halliburton is continuing its digital transformation, including investment in electric fracturing fleets, automated drilling, and carbon capture related services. For you as an investor following oilfield services, this move at Halliburton (NYSE:HAL) sits at...

IMAX’s exclusive Dune Part Three run puts premium screens in focus IMAX (IMAX) is back in the spotlight after Warner Bros. confirmed Dune Part Three will occupy all IMAX screens for three weeks from December 18, 2026, concentrating premium box office demand on the format. See our latest analysis for IMAX. The Dune Part Three announcement lands after a strong run in IMAX’s shares, with a 7 day share price return of 9.14% and a 90 day share price return of 17.31%, while the 1 year total...

Why Albemarle Is Back on Many Investors’ Screens Albemarle (ALB) is drawing fresh attention after a strong past 3 months, with the stock up about 89%, while recent annual results combine growing revenue with a reported net loss and a current share price of $172.54. See our latest analysis for Albemarle. Beyond the recent 18.3% 30 day share price return and the 5.8% gain in the last session, Albemarle’s 87.3% one year total shareholder return contrasts with a 31.8% total shareholder return...

Why Insmed’s latest update matters for shareholders Insmed (INSM) recently issued preliminary 2025 figures and fresh guidance, highlighting revenue contributions from ARIKAYCE and BRINSUPRI, along with plans for an expected EU launch and several late stage clinical readouts in 2026. See our latest analysis for Insmed. The guidance update comes after a mixed few months for the share price, with a 6.48% 30 day share price return decline and a 7.68% year to date share price return. At the same...

Boston Beer Company (SAM) is back in the spotlight after expanding its TeaPot cannabis beverage line with Blueberry Chamomile, a non carbonated iced tea infused with 10mg of rosin derived THC for evening consumption. See our latest analysis for Boston Beer Company. The TeaPot expansion lands at a time when Boston Beer Company’s share price has a 1 day return of 5.28% and a 30 day share price return of 8.50%. However, its 1 year total shareholder return of 14.10% and 5 year total shareholder...

In January 2026, ServiceTitan announced that Southern Home Services became the first enterprise-size business to adopt its Max Program, integrating native AI across demand generation, dispatching, and job execution. A few days earlier, ServiceTitan also introduced AI-driven Accounts Payable Automation, Tap to Pay mobile payments, and integrated financing, deepening its role as an all-in-one fintech and operations platform for contractors. We’ll now examine how end-to-end AI automation for...

What triggered the sharp move in Alvotech? Alvotech (ALVO) shares fell sharply after reports of potential securities claims tied to allegedly misleading business information, together with an FDA complete response letter citing deficiencies at the company’s Reykjavik manufacturing facility. See our latest analysis for Alvotech. Those legal and regulatory setbacks land on top of a weak backdrop, with a 90 day share price return of a 39.73% decline and a 1 year total shareholder return of a...

The Trump administration, working with Mid-Atlantic governors, recently moved to impose price caps and push emergency auctions in the PJM power grid, raising questions about how Constellation Energy can monetize its large nuclear and gas generation portfolio in that region. An underappreciated angle is that while the policy may restrict pricing on existing plants, it could also channel long-term contracts toward new Constellation-backed capacity builds. We’ll now examine how these new PJM...

Quest Diagnostics (NYSE:DGX) has partnered with Visby Medical to offer an at-home, FDA authorized PCR test focused on women's sexual health. The new test targets common STIs and is available directly through Quest's consumer-initiated testing platform. This move aims to reduce access barriers for STI screening and aligns with broader demand for convenient, at-home diagnostics. For investors watching NYSE:DGX, this new offering adds another consumer-focused service on top of an existing...

Halozyme Therapeutics (NasdaqGS:HALO) has signed a global collaboration and exclusive license agreement with Takeda. The deal gives Takeda access to Halozyme's ENHANZE drug delivery technology for use with vedolizumab. Vedolizumab is used in the treatment of Crohn's disease and ulcerative colitis. The agreement includes upfront, milestone, and royalty payments to Halozyme. For you as an investor, this agreement ties Halozyme's ENHANZE platform directly to a globally marketed...

Recent analyst moves have put Vertex Pharmaceuticals (VRTX) back in focus, with Bernstein upgrading the stock and UBS initiating coverage. Both firms point to cystic fibrosis strength and upcoming 2026 to 2027 data readouts. See our latest analysis for Vertex Pharmaceuticals. Vertex shares now trade at US$442.08, with a softer 30 day share price return of a 3.1% decline and a year to date share price return of a 2.2% decline, contrasting with a 5 year total shareholder return of 86.03%. This...